Yahoo
NasdaqGS - BOATS Real Time Price USD

Intuitive Surgical, Inc. (ISRG)

399.69 -2.14 (-0.53%)
At close: June 25 at 4:00:01 PM EDT
400.46 +0.77 (+0.19%)
Overnight: 1:00:15 AM EDT
Trade ISRG on Coinbase
Chart Range Bar
Loading chart for ISRG
Chart does not reflect overnight price.

News headlines Intuitive Surgical (ISRG) is facing scrutiny over instrument reuse regulations, impacting its stock performance. Analysts from Goldman Sachs remain optimistic, maintaining a $558 target pricedespite a 28% declinein shares this year. The company has reported strong revenue growth and raised its procedure growth outlook for 2026, yet regulatory challenges loom ahead.

Intuitive Surgical (ISRG) is facing scrutiny over instrument reuse regulations, impacting its stock performance. Analysts from Goldman Sachs remain optimistic, maintaining a $558 target pricedespite a 28% declinein shares this year. The company has reported strong revenue growth and raised its procedure growth outlook for 2026, yet regulatory challenges loom ahead.

Updated 9m ago · Powered by Yahoo Scout
  • Previous Close 401.83
  • Open 403.21
  • Bid 402.27 x 100
  • Ask 406.15 x 100
  • Day's Range 398.89 - 412.47
  • 52 Week Range 396.68 - 603.88
  • Volume 2,724,095
  • Avg. Volume 2,336,538
  • Market Cap (intraday) 141.555B
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) 48.57
  • EPS (TTM) 8.23
  • Earnings Date Jul 16, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 565.08

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

17,021

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 6/25/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ISRG
29.43%
S&P 500 (^GSPC)
7.48%

1-Year Return

ISRG
23.38%
S&P 500 (^GSPC)
20.77%

3-Year Return

ISRG
22.13%
S&P 500 (^GSPC)
69.20%

5-Year Return

ISRG
32.01%
S&P 500 (^GSPC)
71.88%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 2.77B
Earnings 901.1M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
1B
2B

Analyst Insights

View More

Analyst Price Targets

366.00
565.08 Average
399.69 Current
750.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/18/2026
Analyst B of A Securities
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 650 -> 520

Statistics

View More

Valuation Measures

Annual
As of 6/25/2026
  • Market Cap

    141.56B

  • Enterprise Value

    137.04B

  • Trailing P/E

    48.57

  • Forward P/E

    38.61

  • PEG Ratio (5yr expected)

    2.10

  • Price/Sales (ttm)

    13.65

  • Price/Book (mrq)

    8.10

  • Enterprise Value/Revenue

    12.95

  • Enterprise Value/EBITDA

    34.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    28.15%

  • Return on Assets (ttm)

    10.24%

  • Return on Equity (ttm)

    17.23%

  • Revenue (ttm)

    10.58B

  • Net Income Avi to Common (ttm)

    2.98B

  • Diluted EPS (ttm)

    8.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.52B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.25B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

399.69 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Intuitive Earnings: Procedure Growth Driven by After-Hours Volume; Margins' Performance in Line

    Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
  • Intuitive Earnings: Procedure Growth Driven by After-Hours Volume; Margins' Performance in Line

    Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
  • Intuitive Earnings: Procedure Growth Driven by After-Hours Volume; Margins' Performance in Line

    Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
  • BUY on trading pullback

    Intuitive Surgical designs, manufactures, and markets da Vinci robotic surgical systems and related instruments and accessories in the U.S. and internationally. The da Vinci system enables surgeons to perform a wide range of surgical procedures with shorter recovery periods and higher patient comfort. The company was founded in 1995 and is headquartered in Sunnyvale, California.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: